查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
微射流的全球市场：按产品、按材料、按应用（诊断、研究、治疗）、按最终用户 - 预测（截至 2029 年）
市场调查报告书
商品编码
1568350

微射流的全球市场：按产品、按材料、按应用（诊断、研究、治疗）、按最终用户 - 预测（截至 2029 年）

Microfluidics Market by Product (Chip, Sensor, Valve, Pump, Needle), Material (Silicon, Polymer), Application (Diagnostics (Clinical, PoC), Research (Proteomic, Genomics, Cell), Therapeutics (Drug Delivery, Wearables)), End User- Global Forecast to 2029
出版日期: | 出版商: MarketsandMarkets | 英文 361 Pages | 订单完成后即时交付

价格

微射流市场规模预计将从 2024 年的 224.3 亿美元成长到 2029 年的 326.7 亿美元，预测期内复合年增长率为 7.8%。

由于许多重要因素，微射流市场正在成长。对照护现场诊断的需求不断增长是关键因素之一。癌症和糖尿病等慢性疾病的增加增加了对快速准确诊断的需求，这推动了微射流在医疗保健中的应用。此外，药物输送、晶片器官技术和个人化医疗等创新正在增加微射流设备的使用。此外，蛋白质体学和基因组学相关研究的增加也推动了市场的发展。

调查范围
调查年份 2022-2029
基准年 2023年
预测期 2024-2029
单元 金额（美元）
按细分市场 按产品/应用程式/最终用户/地区
目标区域 北美、欧洲、亚太地区、拉丁美洲、中东和非洲

“2023年聚合物产业将占据最大份额”

微射流市场由聚合物材料驱动，因为它们成本低、易于製造且适应性强。微射流装置的製造通常需要聚二甲基硅氧烷（PDMS）、聚甲基丙烯酸甲酯（PMMA）和环烯烃共聚物（COC）等聚合物。这些聚合物可用于製造微通道和结构。此外，与有机硅和玻璃等传统材料相比，聚合物更容易成型且製造成本更低。聚合物的生物相容性使其可用于各种医疗应用，包括药物传输、实验室晶片和诊断。由于这些优势，高分子材料在微射流市场中占有最大的份额。

“预计医院和诊断中心行业将在预测期内实现最高增长率”

对于最终用户来说，各种重要因素正在推动医院和诊断中心领域的成长。一个关键因素是对照护现场诊断的需求不断增长。照护现场诊断提供快速的现场测试并改善患者的治疗结果。微射流发挥重要作用，因为它提供更快、更准确的结果。此外，COVID-19 等感染疾病的增加增加了对临床环境中有效诊断的需求。这些设备降低了成本，加快了测试速度，并提高了诊断精度和准确度。

“预计亚太地区在预测期内将呈现最高的市场成长率”

亚太地区包括印度、中国、日本、澳洲、韩国等地区。对创新技术的需求正在增加，特别是在中国、印度和日本。由于慢性病和感染疾病病率的上升，以及对早期诊断和预防性医疗保健的日益关注，微射流设备在诊断和治疗应用中的使用正在扩大。该地区的製药和生命科学产业也在采取研发倡议，增加了个人化医疗和药物发现中对微射流的需求。

本报告调查了全球微射流市场，并提供了市场概况、市场成长的各种影响因素分析、技术和专利趋势、法律制度、案例研究、市场规模趋势和预测以及各种分类。环境、主要企业概况等

目录

第一章简介

第二章调查方法

第三章执行摘要

第 4 章重要考察

第五章市场概况

  • 市场动态
    • 促进因素
    • 抑制因素
    • 机会
    • 任务
  • 产业动态
  • 波特五力分析
  • 主要相关利益者和采购标准
  • 监管状况
  • 赎回场景
  • 生态系分析
  • 价值链分析
  • 供应链分析
  • 影响客户业务的趋势/干扰
  • 生成式人工智慧对微射流市场的影响
  • 专利分析
  • 贸易分析
  • 技术分析
  • 重大会议及活动
  • 价格分析
  • 未满足的需求/最终用户的期望
  • 案例研究分析
  • 投资金筹措场景

第六章微射流市场：副产品

  • 装置
  • 成分
    • 组件：按类型
    • 成分： 按材质

第七章微射流市场：依应用分类

  • 体外诊断
    • 临床诊断
    • 就地检验
    • 兽医诊断
  • 製药与生命科学研究
    • 实验室分析
    • 微量点胶
    • 微型反应器
  • 治疗药物
    • 药物输送
    • 穿戴式装置

第八章微射流市场：依最终用户分类

  • 医院/诊断中心
  • 学术/研究机构
  • 製药和生物技术公司

第九章微射流市场：按地区

  • 北美洲
  • 欧洲
  • 亚太地区
  • 拉丁美洲
  • 中东/非洲

第10章竞争格局

  • 主要企业/主要企业策略
  • 主要企业采取的策略概览
  • 收益分析
  • 主要企业市场占有率分析
  • 主要企业排名
  • 企业评价矩阵：主要企业
  • 公司评估矩阵：Start-Ups企业/中小企业
  • 公司评价及财务指标
  • 品牌/产品比较分析
  • 竞争场景

第十一章 公司简介

  • 主要企业
    • DANAHER CORPORATION
    • ILLUMINA, INC.
    • BIOMERIEUX
    • THERMO FISHER SCIENTIFIC INC.
    • ABBOTT LABORATORIES
    • PARKER HANNIFIN CORP
    • SMC CORPORATION
    • IDEX CORPORATION
    • FORTIVE
    • PERKINELMER INC.
    • AGILENT TECHNOLOGIES, INC.
    • BIO-RAD LABORATORIES, INC.
    • BECTON, DICKINSON AND COMPANY
    • F. HOFFMANN-LA ROCHE LTD.
    • STANDARD BIOTOOLS
    • QUIDELORTHO CORPORATION
    • HOLOGIC, INC.
    • AIGNEP SPA
    • DOLOMITE MICROFLUIDICS
    • ELVEFLOW
  • 其他公司
    • NANOSTRING TECHNOLOGIES
    • NORTIS INC.
    • INNOVATIVE BIOCHIPS, LLC
    • FLUIDIC ANALYTICS
    • UFLUIDIX
    • HORIBA
    • MICRONIT BV

第十二章附录

Product Code: AST 7541

The Microfluidics market is projected to reach USD 32.67 Billion by 2029 from USD 22.43 in 2024, growing at a CAGR of 7.8% during the forecast period. The market for microfluidics is expanding due to a number of important factors. The growing requirement for point-of-care diagnostics is one of an important factor. The necessity for fast and accurate diagnosis has risen due to the increase in chronic diseases like cancer and diabetes, which is propelling the application of microfluidics in healthcare. Furthermore, the use of microfluidic devices is increasing due to innovations in drug delivery , organ-on-a-chip technology, and personalized medicine. Additionally, the market is driven by the rise in proteomics and genomics associated research.

Scope of the Report
Years Considered for the Study2022-2029
Base Year2023
Forecast Period2024-2029
Units ConsideredValue (USD Million/USD Billion)
SegmentsBy Product, Application, End User, and Region
Regions coveredNorth America, Europe, Asia Pacific, Latin America, and the Middle East & Africa

"Polymers to account for largest market share in 2023."

The market for microfluidics is propelled by polymers because of their their low costs, ease of production and adaptability. Microfluidic device manufacturing often requires polymers such as polydimethylsiloxane (PDMS), polymethyl methacrylate (PMMA), and cyclic olefin copolymer (COC). These polymers are helpful in the fabrication of microfluidic channels and structures. Moreover, as compared to conventional materials like silicon or glass, polymers are easier to mold and also, enables cheaper manufacturing costs. The biocompatible property of polymers makes them useful for a variety of medical applications, including medication delivery, lab-on-a-chip, and diagnostics. Due to such advantages, polymers accounts for the largest share in the microfluidics market.

"Hospital and Diagnostic Centers to register highest growth rate in the market during the forecast period."

Various significant factors are propelling the growth of hospitals and diagnostic centers in the microfluidics industry. One important factor is the rising requirement for point-of-care diagnostics, as they provides quick, on-site testing that improves patient outcomes. Microfluidics play a major role in this positive outcome as it offers faster and precise result . Moreover, the requirement for efficacious diagnostics in clinical settings has risen due to the increase in infectious diseases like COVID-19. These equipment decreases cost, expedites testing methods, and improve precision and accuracy of diagnosis.

"Asia Pacific to register highest growth rate in the market during the forecast period."

The highest CAGR was registered by the APAC region throughout the forecast period from 2024-2029. Asia Pacific comprise India, China, Japan, Australia, South Korea and RoAPAC. The demand for innovative technologies is increasing, especially in China, India, and Japan. Microfluidic devices for diagnostic and therapeutic applications are used due to the rise in prevalence of chronic and infectious diseases and the increase in focus on early diagnosis and preventative healthcare. The region's rising pharmaceutical and lifesciences industries are also undertaking research and development initiatives, which increases the requirement for microfluidics in personalized medicine and drug discovery.

A breakdown of the primary participants referred to for this report is provided below:

  • By Company Type: Tier 1-30%, Tier 2-42%, and Tier 3- 28%
  • By Designation: C-level-- 14%, Director-level-10%, and Others-76%
  • By Region: North America-40%, Europe-30%, Asia Pacific-22%, Rest of the World -8%.

Prominent players in this market are Abbott laboratories (US) , Agilent Technologies, Inc. (US), Aignep S.P.A (Italy), biomerieux (France), BD(US), Bio-Rad laboratories, Inc (US), Danaher Corporation (US), Illumina Inc. (US), Parker Hannifin Corporation (US), Thermo Fisher Scientific Inc. (US), SMC Corporation (Japan), Idex Corporation (US), Fortive Corporation (US), Perkinelmer, Inc. (US), F.Hoffmann-LA Roche Ltd (Switzerland), Standard Biotools Inc. (US), Quidelortho Corporation (US), Hologic Inc. (US), Dolomite Microfluidics (UK) and Elveflow (France).

Research Coverage

The report comprise segmentation that covers end users, products, applications, and geographic regions. It also covers the key drivers, restraints, opportunities, and challenges impacting the growth trajectory of the microfluidics market. The research offers stakeholders an in-depth analysis of market potential and challenges, with a focus on major players and competitive landscapes. Moreover, micromarkets are analysed as per their overall impact to the global microfluidics sector, growth patterns, and potential. The analysis forecasts rise in market segment revenues, focusing on five key regions.

Key Benefits of Buying the Report:

The purpose of this research is to assist both new and existing players in the microfluidics market to assess the sustainability of their investments by providing detailed and knowledgeable information. It offers a dataset to assist in making key decisions. This report's potential to facilitate thorough risk evaluation and provide direction for investment decisions is one of its major benefit. Market segmentation according to end-users and geographical areas is provided in the study, that provides precise analysis and insights. It also provide significant trends, obstacles, opportunities, and drivers, giving stakeholders the information they require to make strategic decisions that help in their long-term growth.

The report provides the insights on the following pointers:

Analysis of the key drivers, restraints, opportunities, and challenges affecting the microfluidics market growth: Innovative technology and increase in prevalence of chronic diseases ; increased cost of devices and stringent regulations ; increase in number of diagnostic centers.

Product Development/Innovation: Overview of technologies, research & development ventures and launch of innovative product & service for the microfluidics industry.

Market Development: Details associated with profitable markets: this research studies the microfluidics business in various geographical regions.

Market Diversification: In-depth understanding of innovative products, unexamined regions, recent developments, and expenditures in the microfluidics market.

Competitive Assessment: Detailed analysis of market share, services and products offered and key strategies adopted by prominent players such as Danaher Corporation (US), Illumina Inc. (US), biomerieux (France), Thermo Fisher Scientific Inc. (US) and Abbott laboratories (US).

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 STUDY OBJECTIVES
  • 1.2 MARKET DEFINITION
  • 1.3 MARKET SCOPE
    • 1.3.1 MARKETS COVERED
    • 1.3.2 INCLUSIONS & EXCLUSIONS
    • 1.3.3 YEARS CONSIDERED
    • 1.3.4 CURRENCY CONSIDERED
  • 1.4 MARKET STAKEHOLDERS
  • 1.5 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY

  • 2.1 RESEARCH DATA
  • 2.2 RESEARCH DESIGN
    • 2.2.1 SECONDARY RESEARCH
      • 2.2.1.1 Key data from secondary sources
    • 2.2.2 PRIMARY RESEARCH
      • 2.2.2.1 Key industry insights
  • 2.3 MARKET SIZE ESTIMATION METHODOLOGY
    • 2.3.1 BOTTOM-UP APPROACH
      • 2.3.1.1 Approach 1: Company revenue estimation approach
      • 2.3.1.2 Approach 2: Customer-based market estimation
      • 2.3.1.3 Approach 3: Top-down approach
      • 2.3.1.4 Approach 4: Primary interviews
      • 2.3.1.5 Growth forecast
      • 2.3.1.6 CAGR projection
    • 2.3.2 TOP-DOWN APPROACH
  • 2.4 MARKET BREAKDOWN AND DATA TRIANGULATION
  • 2.5 MARKET SHARE ASSESSMENT
  • 2.6 RESEARCH ASSUMPTIONS
  • 2.7 RESEARCH LIMITATIONS
  • 2.8 RISK ASSESSMENT

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

  • 4.1 MICROFLUIDICS MARKET OVERVIEW
  • 4.2 ASIA PACIFIC: MICROFLUIDICS MARKET, BY END USER AND COUNTRY (2023)
  • 4.3 MICROFLUIDICS MARKET, BY REGION
  • 4.4 GEOGRAPHIC SNAPSHOT OF MICROFLUIDICS MARKET

5 MARKET OVERVIEW

  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    • 5.2.1 DRIVERS
      • 5.2.1.1 Growing requirement for point-of-care testing
      • 5.2.1.2 Rising technological advancements
      • 5.2.1.3 Increasing focus on data precision and accuracy
      • 5.2.1.4 Economic benefits associated with microfluidics
      • 5.2.1.5 Portability with microfluidic chip miniaturization
      • 5.2.1.6 Rising demand for effective sample analysis
    • 5.2.2 RESTRAINTS
      • 5.2.2.1 Stringent regulatory approval process
      • 5.2.2.2 Integration of microfluidics into current workflow
    • 5.2.3 OPPORTUNITIES
      • 5.2.3.1 Emergence of 3D cell culture systems
      • 5.2.3.2 Growth potential of emerging economies
      • 5.2.3.3 Use of microfluidics in life sciences & pharmaceutical industries
    • 5.2.4 CHALLENGES
      • 5.2.4.1 Low adoption of microfluidic devices among end users
  • 5.3 INDUSTRY TRENDS
    • 5.3.1 E-HEALTH DIAGNOSTICS
    • 5.3.2 INTEGRATION OF MICROFLUIDICS WITH 3D PRINTING
    • 5.3.3 R&D INVESTMENTS FOR PRODUCT DEVELOPMENT
  • 5.4 PORTER'S FIVE FORCES ANALYSIS
    • 5.4.1 THREAT OF NEW ENTRANTS
    • 5.4.2 THREAT OF SUBSTITUTES
    • 5.4.3 BARGAINING POWER OF SUPPLIERS
    • 5.4.4 BARGAINING POWER OF BUYERS
    • 5.4.5 INTENSITY OF COMPETITIVE RIVALRY
  • 5.5 KEY STAKEHOLDERS & BUYING CRITERIA
    • 5.5.1 KEY STAKEHOLDERS IN BUYING PROCESS
    • 5.5.2 BUYING CRITERIA
  • 5.6 REGULATORY LANDSCAPE
    • 5.6.1 NORTH AMERICA
      • 5.6.1.1 US
      • 5.6.1.2 Canada
    • 5.6.2 EUROPE
    • 5.6.3 ASIA PACIFIC
      • 5.6.3.1 Japan
      • 5.6.3.2 China
      • 5.6.3.3 India
    • 5.6.4 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • 5.7 REIMBURSEMENT SCENARIO
  • 5.8 ECOSYSTEM ANALYSIS
  • 5.9 VALUE CHAIN ANALYSIS
    • 5.9.1 RESEARCH & DEVELOPMENT
    • 5.9.2 RAW MATERIAL PROCUREMENT & MANUFACTURING
    • 5.9.3 MARKETING & SALES, DISTRIBUTION, AND POST-SALES SERVICES
  • 5.10 SUPPLY CHAIN ANALYSIS
  • 5.11 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES
  • 5.12 IMPACT OF GEN AI ON MICROFLUIDICS MARKET
  • 5.13 PATENT ANALYSIS
    • 5.13.1 PATENT PUBLICATION TRENDS FOR MICROFLUIDICS
    • 5.13.2 INSIGHTS: JURISDICTION AND TOP APPLICANT ANALYSIS
  • 5.14 TRADE ANALYSIS
    • 5.14.1 IMPORT DATA
    • 5.14.2 EXPORT DATA
  • 5.15 TECHNOLOGY ANALYSIS
    • 5.15.1 KEY TECHNOLOGIES
      • 5.15.1.1 Biosensor elements
      • 5.15.1.2 Materials science
      • 5.15.1.3 Microfabrication
      • 5.15.1.4 Direct-writing
    • 5.15.2 COMPLEMENTARY TECHNOLOGIES
      • 5.15.2.1 MEMS
        • 5.15.2.1.1 Green microfluidics
        • 5.15.2.1.2 Microsensors/transducers
    • 5.15.3 ADJACENT TECHNOLOGIES
      • 5.15.3.1 3D inkjet printing
      • 5.15.3.2 Lab-on-fiber
  • 5.16 KEY CONFERENCES & EVENTS
  • 5.17 PRICING ANALYSIS
    • 5.17.1 AVERAGE SELLING PRICE TREND, BY REGION
    • 5.17.2 AVERAGE SELLING PRICE TREND OF TOP 3 APPLICATIONS, BY KEY PLAYER
  • 5.18 UNMET NEEDS/END-USER EXPECTATIONS IN MICROFLUIDICS MARKET
  • 5.19 CASE STUDY ANALYSIS
    • 5.19.1 CASE STUDY 1: MULTIPLEX MICROFLUIDIC CIRCUIT FOR BLOOD VESSEL-ON-A-CHIP PERFUSION USING FLOWEZ
    • 5.19.2 CASE STUDY 2: MICROFLUIDIC SYSTEM FOR ROBOTIC HAND PLAYING NINTENDO
    • 5.19.3 CASE STUDY 3: 3D-PRINTED MICROFLUIDIC DEVICES USING POLYJET TECHNOLOGY
  • 5.20 INVESTMENT & FUNDING SCENARIO

6 MICROFLUIDICS MARKET, BY PRODUCT

  • 6.1 INTRODUCTION
  • 6.2 MICROFLUIDICS-BASED DEVICES
    • 6.2.1 HIGH UPTAKE OF POC TESTING AND ORGAN-ON-A-CHIP SYSTEMS TO PROPEL MARKET
  • 6.3 MICROFLUIDIC COMPONENTS
    • 6.3.1 MICROFLUIDIC COMPONENTS, BY TYPE
      • 6.3.1.1 Microfluidic chips
        • 6.3.1.1.1 Chips to account for largest share of components market
      • 6.3.1.2 Flow & pressure sensors
        • 6.3.1.2.1 Utilization in lab diagnostics & research applications to drive market
      • 6.3.1.3 Flow & pressure controllers
        • 6.3.1.3.1 Cost-effectiveness and durability to boost demand
      • 6.3.1.4 Microfluidic valves
        • 6.3.1.4.1 Technological advancements to support market growth
      • 6.3.1.5 Micropumps
        • 6.3.1.5.1 Wide usage in drug delivery and glucose injections to fuel uptake
      • 6.3.1.6 Microneedles
        • 6.3.1.6.1 Miniscule size and painless patch application procedure to boost demand
      • 6.3.1.7 Other microfluidic components
    • 6.3.2 MICROFLUIDIC COMPONENTS, BY MATERIAL
      • 6.3.2.1 Silicon
        • 6.3.2.1.1 High precision and durability to boost demand
      • 6.3.2.2 Polymers
        • 6.3.2.2.1 Polymethyl Methacrylate (PMMA)
          • 6.3.2.2.1.1 Durable alternative to glass to fuel uptake
        • 6.3.2.2.2 Polydimethylsiloxane (PDMS)
          • 6.3.2.2.2.1 Limited compatibility with specific solvents and acids to limit market adoption
        • 6.3.2.2.3 Cyclic Olefin Copolymers
          • 6.3.2.2.3.1 Low water absorption and enhanced electrical insulation properties to boost demand
        • 6.3.2.2.4 Other polymers
      • 6.3.2.3 Glass
        • 6.3.2.3.1 High cost and brittleness to restrain market

7 MICROFLUIDICS MARKET, BY APPLICATION

  • 7.1 INTRODUCTION
  • 7.2 IVD
    • 7.2.1 CLINICAL DIAGNOSTICS
      • 7.2.1.1 Growing focus on early disease detection to drive market
    • 7.2.2 POINT-OF-CARE TESTING (POCT)
      • 7.2.2.1 High uptake of lab-on-a-chip technologies to fuel uptake
    • 7.2.3 VETERINARY DIAGNOSTICS
      • 7.2.3.1 Detection of toxins in food through LOC systems to support market growth
  • 7.3 PHARMACEUTICAL & LIFE SCIENCE RESEARCH
    • 7.3.1 LAB ANALYTICS
      • 7.3.1.1 Proteomic analysis
        • 7.3.1.1.1 Utilization of lab-on-a-chip devices for therapeutic development to drive market
      • 7.3.1.2 Genomic analysis
        • 7.3.1.2.1 Growing focus on NGS and digital PCR to boost demand
      • 7.3.1.3 Cell-based assays
        • 7.3.1.3.1 Drug-screening for cross-reaction & toxicity testing to support market growth
      • 7.3.1.4 Capillary electrophoresis
        • 7.3.1.4.1 Growing applications for environmental monitoring and clinical diagnostics to fuel uptake
    • 7.3.2 MICRODISPENSING
      • 7.3.2.1 Suitability for low-viscosity applications to support market growth
    • 7.3.3 MICROREACTORS
      • 7.3.3.1 High uptake by leading companies for process optimization to fuel market
  • 7.4 THERAPEUTICS
    • 7.4.1 DRUG DELIVERY
      • 7.4.1.1 Utilization of microneedles for painless and precise delivery to drive market
    • 7.4.2 WEARABLE DEVICES
      • 7.4.2.1 Integration of microfluidics-based wearable devices to support market growth

8 MICROFLUIDICS MARKET, BY END USER

  • 8.1 INTRODUCTION
  • 8.2 HOSPITALS AND DIAGNOSTIC CENTERS
    • 8.2.1 AVAILABILITY OF TECHNOLOGICALLY ADVANCED EQUIPMENT AND FOCUS ON EARLY DISEASE DIAGNOSIS TO BOOST DEMAND
  • 8.3 ACADEMIC & RESEARCH INSTITUTES
    • 8.3.1 INVESTMENTS IN BIOMEDICAL & LIFE SCIENCE RESEARCH TO SUPPORT MARKET GROWTH
  • 8.4 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
    • 8.4.1 GROWING FOCUS ON BIOMARKER & DRUG DISCOVERY TO PROPEL MARKET

9 MICROFLUIDICS MARKET, BY REGION

  • 9.1 INTRODUCTION
  • 9.2 NORTH AMERICA
    • 9.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA
    • 9.2.2 US
      • 9.2.2.1 High healthcare expenditure and wide adoption of technologically advanced products to drive market
    • 9.2.3 CANADA
      • 9.2.3.1 Government funds and focus on research to support market growth
  • 9.3 EUROPE
    • 9.3.1 MACROECONOMIC OUTLOOK FOR EUROPE
    • 9.3.2 GERMANY
      • 9.3.2.1 Growing focus on proteomics & genomics research to drive market
    • 9.3.3 FRANCE
      • 9.3.3.1 Favorable government support for R&D to drive market
    • 9.3.4 UK
      • 9.3.4.1 Rising cases of chronic diseases and increasing demand for POC testing to boost demand
    • 9.3.5 ITALY
      • 9.3.5.1 Innovative development of microfluidic chips to boost demand
    • 9.3.6 SPAIN
      • 9.3.6.1 Growth in pharmaceutical industry to fuel uptake
    • 9.3.7 REST OF EUROPE
  • 9.4 ASIA PACIFIC
    • 9.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
    • 9.4.2 CHINA
      • 9.4.2.1 Growing focus on nanotechnology to drive market
    • 9.4.3 JAPAN
      • 9.4.3.1 High investments in academic research activities to propel market
    • 9.4.4 INDIA
      • 9.4.4.1 Increasing prevalence of CVD and diabetes to support market growth
    • 9.4.5 AUSTRALIA
      • 9.4.5.1 Rising incidence of infectious diseases to fuel uptake
    • 9.4.6 SOUTH KOREA
      • 9.4.6.1 Increasing R&D expenditure to drive growth
    • 9.4.7 REST OF ASIA PACIFIC
  • 9.5 LATIN AMERICA
    • 9.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA
    • 9.5.2 BRAZIL
      • 9.5.2.1 Increasing development of disease diagnostics kits to fuel uptake
    • 9.5.3 MEXICO
      • 9.5.3.1 Rising prevalence of chronic diseases to boost demand for POC testing
    • 9.5.4 REST OF LATIN AMERICA
  • 9.6 MIDDLE EAST & AFRICA
    • 9.6.1 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA
    • 9.6.2 GCC COUNTRIES
      • 9.6.2.1 Adoption of advanced microfluidic devices to support market growth
    • 9.6.3 REST OF MIDDLE EAST & AFRICA

10 COMPETITIVE LANDSCAPE

  • 10.1 INTRODUCTION
  • 10.2 KEY PLAYER STRATEGY/RIGHT TO WIN
  • 10.3 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN MICROFLUIDICS MARKET
  • 10.4 REVENUE ANALYSIS
  • 10.5 MARKET SHARE ANALYSIS BY KEY PLAYERS,2023
  • 10.6 RANKING OF KEY MARKET PLAYERS
  • 10.7 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023
    • 10.7.1 STARS
    • 10.7.2 EMERGING LEADERS
    • 10.7.3 PERVASIVE PLAYERS
    • 10.7.4 PARTICIPANTS
    • 10.7.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023
      • 10.7.5.1 Company footprint
      • 10.7.5.2 Product footprint
      • 10.7.5.3 Application footprint
      • 10.7.5.4 End-user footprint
      • 10.7.5.5 Region footprint
  • 10.8 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023
    • 10.8.1 PROGRESSIVE COMPANIES
    • 10.8.2 RESPONSIVE COMPANIES
    • 10.8.3 DYNAMIC COMPANIES
    • 10.8.4 STARTING BLOCKS
    • 10.8.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023
      • 10.8.5.1 Detailed list of key startup/SME players
      • 10.8.5.2 Competitive benchmarking of key emerging players/startups
  • 10.9 COMPANY VALUATION & FINANCIAL METRICS
    • 10.9.1 FINANCIAL METRICS
    • 10.9.2 COMPANY VALUATION
  • 10.10 BRAND/PRODUCT COMPARATIVE ANALYSIS
  • 10.11 COMPETITIVE SCENARIO
    • 10.11.1 PRODUCT LAUNCHES & APPROVALS
    • 10.11.2 DEALS
    • 10.11.3 EXPANSIONS
    • 10.11.4 OTHER DEVELOPMENTS

11 COMPANY PROFILES

  • 11.1 KEY PLAYERS
    • 11.1.1 DANAHER CORPORATION
      • 11.1.1.1 Business overview
      • 11.1.1.2 Products offered
      • 11.1.1.3 Recent developments
        • 11.1.1.3.1 Deals
        • 11.1.1.3.2 Expansions
      • 11.1.1.4 MnM view
        • 11.1.1.4.1 Key strengths
        • 11.1.1.4.2 Strategic choices
        • 11.1.1.4.3 Weaknesses & competitive threats
    • 11.1.2 ILLUMINA, INC.
      • 11.1.2.1 Business overview
      • 11.1.2.2 Products offered
      • 11.1.2.3 Recent developments
        • 11.1.2.3.1 Product launches & approvals
        • 11.1.2.3.2 Deals
      • 11.1.2.4 MnM view
        • 11.1.2.4.1 Key strengths
        • 11.1.2.4.2 Strategic choices
        • 11.1.2.4.3 Weaknesses & competitive threats
    • 11.1.3 BIOMERIEUX
      • 11.1.3.1 Business overview
      • 11.1.3.2 Products offered
      • 11.1.3.3 Recent developments
        • 11.1.3.3.1 Product launches & approvals
      • 11.1.3.4 MnM view
        • 11.1.3.4.1 Key strengths
        • 11.1.3.4.2 Strategic choices
        • 11.1.3.4.3 Weaknesses & competitive threats
    • 11.1.4 THERMO FISHER SCIENTIFIC INC.
      • 11.1.4.1 Business overview
      • 11.1.4.2 Products offered
      • 11.1.4.3 Recent developments
        • 11.1.4.3.1 Product launches & approvals
        • 11.1.4.3.2 Deals
        • 11.1.4.3.3 Expansions
      • 11.1.4.4 MnM view
        • 11.1.4.4.1 Key strengths
        • 11.1.4.4.2 Strategic choices
        • 11.1.4.4.3 Weaknesses & competitive threats
    • 11.1.5 ABBOTT LABORATORIES
      • 11.1.5.1 Business overview
      • 11.1.5.2 Products offered
      • 11.1.5.3 MnM view
        • 11.1.5.3.1 Key strengths
        • 11.1.5.3.2 Strategic choices
        • 11.1.5.3.3 Weaknesses & competitive threats
    • 11.1.6 PARKER HANNIFIN CORP
      • 11.1.6.1 Business overview
      • 11.1.6.2 Products offered
    • 11.1.7 SMC CORPORATION
      • 11.1.7.1 Business overview
      • 11.1.7.2 Products offered
      • 11.1.7.3 Recent developments
        • 11.1.7.3.1 Product launches
    • 11.1.8 IDEX CORPORATION
      • 11.1.8.1 Business overview
      • 11.1.8.2 Products offered
      • 11.1.8.3 Recent developments
        • 11.1.8.3.1 Deals
    • 11.1.9 FORTIVE
      • 11.1.9.1 Business overview
      • 11.1.9.2 Products offered
    • 11.1.10 PERKINELMER INC.
      • 11.1.10.1 Business overview
      • 11.1.10.2 Products offered
      • 11.1.10.3 Recent developments
        • 11.1.10.3.1 Product launches
        • 11.1.10.3.2 Deals
    • 11.1.11 AGILENT TECHNOLOGIES, INC.
      • 11.1.11.1 Business overview
      • 11.1.11.2 Products offered
      • 11.1.11.3 Recent developments
        • 11.1.11.3.1 Product launches
        • 11.1.11.3.2 Deals
        • 11.1.11.3.3 Expansions
    • 11.1.12 BIO-RAD LABORATORIES, INC.
      • 11.1.12.1 Business overview
      • 11.1.12.2 Products offered
      • 11.1.12.3 Recent developments
        • 11.1.12.3.1 Product launches
        • 11.1.12.3.2 Deals
    • 11.1.13 BECTON, DICKINSON AND COMPANY
      • 11.1.13.1 Business overview
      • 11.1.13.2 Products offered
      • 11.1.13.3 Recent developments
        • 11.1.13.3.1 Product launches & approvals
        • 11.1.13.3.2 Deals
        • 11.1.13.3.3 Expansions
    • 11.1.14 F. HOFFMANN-LA ROCHE LTD.
      • 11.1.14.1 Business overview
      • 11.1.14.2 Products offered
      • 11.1.14.3 Recent developments
        • 11.1.14.3.1 Product launches & approvals
        • 11.1.14.3.2 Deals
    • 11.1.15 STANDARD BIOTOOLS
      • 11.1.15.1 Business overview
      • 11.1.15.2 Products offered
      • 11.1.15.3 Recent developments
        • 11.1.15.3.1 Product launches & approvals
        • 11.1.15.3.2 Deals
    • 11.1.16 QUIDELORTHO CORPORATION
      • 11.1.16.1 Business overview
      • 11.1.16.2 Products offered
      • 11.1.16.3 Recent developments
        • 11.1.16.3.1 Product approvals
        • 11.1.16.3.2 Deals
        • 11.1.16.3.3 Expansions
    • 11.1.17 HOLOGIC, INC.
      • 11.1.17.1 Business overview
      • 11.1.17.2 Products offered
      • 11.1.17.3 Recent developments
        • 11.1.17.3.1 Product approvals
        • 11.1.17.3.2 Deals
    • 11.1.18 AIGNEP S.P.A.
      • 11.1.18.1 Business overview
      • 11.1.18.2 Products offered
      • 11.1.18.3 Recent developments
        • 11.1.18.3.1 Deals
    • 11.1.19 DOLOMITE MICROFLUIDICS
      • 11.1.19.1 Business overview
      • 11.1.19.2 Products offered
      • 11.1.19.3 Recent developments
        • 11.1.19.3.1 Product launches & approvals
        • 11.1.19.3.2 Deals
        • 11.1.19.3.3 Other developments
    • 11.1.20 ELVEFLOW
      • 11.1.20.1 Business overview
      • 11.1.20.2 Products offered
  • 11.2 OTHER PLAYERS
    • 11.2.1 NANOSTRING TECHNOLOGIES
    • 11.2.2 NORTIS INC.
    • 11.2.3 INNOVATIVE BIOCHIPS, LLC
    • 11.2.4 FLUIDIC ANALYTICS
    • 11.2.5 UFLUIDIX
    • 11.2.6 HORIBA
    • 11.2.7 MICRONIT B.V.

12 APPENDIX

  • 12.1 DISCUSSION GUIDE
  • 12.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 12.3 CUSTOMIZATION OPTIONS
  • 12.4 RELATED REPORTS
  • 12.5 AUTHOR DETAILS

List of Tables

  • TABLE 1 MICROFLUIDICS MARKET: INCLUSIONS & EXCLUSIONS
  • TABLE 2 MICROFLUIDICS MARKET: STUDY ASSUMPTIONS
  • TABLE 3 RISK ASSESSMENT: MICROFLUIDICS MARKET
  • TABLE 4 PRODUCT LAUNCHES BY KEY PLAYERS, 2023
  • TABLE 5 LIST OF UNIVERSITY STARTUPS IN MICROFLUIDICS MARKET
  • TABLE 6 MICROFLUIDICS MARKET: PORTER'S FIVE FORCES
  • TABLE 7 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR MICROFLUIDICS MARKET
  • TABLE 8 KEY BUYING CRITERIA FOR MICROFLUIDICS MARKET, BY MATERIAL
  • TABLE 9 US: CLASSIFICATION OF MICROFLUIDICS TECHNOLOGY-ASSOCIATED DIAGNOSTIC DEVICES
  • TABLE 10 CANADA: TIME, COST, AND COMPLEXITY OF REGISTRATION
  • TABLE 11 EUROPE: CLASSIFICATION OF MICROFLUIDICS ASSOCIATED WITH IVD DEVICES
  • TABLE 12 JAPAN: TIME, COST, AND COMPLEXITY OF REGISTRATION
  • TABLE 13 CHINA: TIME, COST, AND COMPLEXITY OF REGISTRATION
  • TABLE 14 NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 15 EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 16 ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 17 LATIN AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 18 REST OF THE WORLD: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 19 MAJOR CPT CODES FOR DIAGNOSTICS TESTS IN US, 2023
  • TABLE 20 MICROFLUIDICS MARKET: ROLE IN ECOSYSTEM
  • TABLE 21 APPLICATIONS OF ARTIFICIAL INTELLIGENCE-POWERED MICROFLUIDICS
  • TABLE 22 LIST OF MAJOR PATENT INNOVATIONS AND PATENT REGISTRATIONS, 2022-2024
  • TABLE 23 IMPORT DATA FOR HS CODE 3822, BY COUNTRY, 2019-2023 (USD THOUSAND)
  • TABLE 24 EXPORT DATA FOR HS CODE 3822, BY COUNTRY, 2019-2023 (USD THOUSAND)
  • TABLE 25 MICROFLUIDICS MARKET: KEY CONFERENCES & EVENTS (2023-2024)
  • TABLE 26 AVERAGE SELLING PRICE OF MICROFLUIDICS MEDICINE EQUIPMENT, BY REGION, 2023 (USD THOUSAND)
  • TABLE 27 AVERAGE SELLING PRICE OF TOP 3 APPLICATIONS, BY KEY PLAYER, 2023 (USD)
  • TABLE 28 MICROFLUIDICS MARKET: CURRENT UNMET NEEDS
  • TABLE 29 CASE STUDY 1: MULTIPLEX MICROFLUIDIC CIRCUIT FOR BLOOD VESSEL-ON-A-CHIP PERFUSION USING FLOWEZ
  • TABLE 30 CASE STUDY 2: MICROFLUIDIC SYSTEM FOR ROBOTIC HAND PLAYING NINTENDO
  • TABLE 31 CASE STUDY 3: 3D-PRINTED MICROFLUIDIC DEVICES USING POLYJET TECHNOLOGY
  • TABLE 32 MICROFLUIDICS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 33 MICROFLUIDICS-BASED DEVICES MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 34 MICROFLUIDIC COMPONENTS MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 35 MICROFLUIDIC COMPONENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 36 MICROFLUIDIC CHIPS OFFERED BY KEY PLAYERS
  • TABLE 37 MICROFLUIDIC CHIPS MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 38 FLOW & PRESSURE SENSORS OFFERED BY KEY PLAYERS
  • TABLE 39 FLOW & PRESSURE SENSORS MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 40 FLOW & PRESSURE CONTROLLERS OFFERED BY KEY PLAYERS
  • TABLE 41 FLOW & PRESSURE CONTROLLERS MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 42 MICROFLUIDIC VALVES OFFERED BY KEY PLAYERS
  • TABLE 43 MICROFLUIDIC VALVES MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 44 MICROPUMPS OFFERED BY KEY PLAYERS
  • TABLE 45 MICROPUMPS MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 46 MICRONEEDLES OFFERED BY KEY PLAYERS
  • TABLE 47 MICRONEEDLES MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 48 OTHER MICROFLUIDIC COMPONENTS MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 49 MICROFLUIDIC COMPONENTS MARKET, BY MATERIAL, 2022-2029 (USD MILLION)
  • TABLE 50 SILICON-BASED MICROFLUIDIC COMPONENTS MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 51 POLYMER-BASED MICROFLUIDIC COMPONENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 52 POLYMER-BASED MICROFLUIDIC COMPONENTS MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 53 PMMA-BASED MICROFLUIDIC COMPONENTS MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 54 PDMS-BASED MICROFLUIDIC COMPONENTS MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 55 COC-BASED MICROFLUIDIC COMPONENTS MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 56 OTHER POLYMER-BASED MICROFLUIDIC COMPONENTS MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 57 GLASS-BASED MICROFLUIDIC COMPONENTS MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 58 MICROFLUIDICS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 59 MICROFLUIDICS MARKET FOR IVD APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 60 MICROFLUIDICS MARKET FOR IVD APPLICATIONS, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 61 MICROFLUIDICS MARKET FOR CLINICAL DIAGNOSTICS, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 62 MICROFLUIDICS MARKET FOR POCT, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 63 MICROFLUIDICS MARKET FOR VETERINARY DIAGNOSTICS, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 64 MICROFLUIDICS MARKET FOR PHARMACEUTICAL & LIFE SCIENCE RESEARCH, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 65 MICROFLUIDICS MARKET FOR PHARMACEUTICAL & LIFE SCIENCE RESEARCH, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 66 MICROFLUIDICS MARKET FOR LAB ANALYTICS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 67 MICROFLUIDICS MARKET FOR LAB ANALYTICS, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 68 MICROFLUIDICS MARKET FOR PROTEOMIC ANALYSIS, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 69 MICROFLUIDICS MARKET FOR GENOMIC ANALYSIS, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 70 MICROFLUIDICS MARKET FOR CELL-BASED ASSAYS, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 71 MICROFLUIDICS MARKET FOR CAPILLARY ELECTROPHORESIS, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 72 MICROFLUIDICS MARKET FOR MICRODISPENSING, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 73 MICROFLUIDICS MARKET FOR MICROREACTORS, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 74 MICROFLUIDICS MARKET FOR THERAPEUTICS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 75 MICROFLUIDICS MARKET FOR THERAPEUTICS, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 76 MICROFLUIDICS MARKET FOR DRUG DELIVERY, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 77 MICROFLUIDICS MARKET FOR WEARABLE DEVICES, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 78 MICROFLUIDICS MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 79 MICROFLUIDICS MARKET FOR HOSPITALS AND DIAGNOSTIC CENTERS, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 80 LEADING MICROFLUIDICS RESEARCH INSTITUTES, BY AREA OF INTEREST
  • TABLE 81 MICROFLUIDICS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 82 MICROFLUIDICS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 83 MICROFLUIDICS MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 84 NORTH AMERICA: MACROECONOMIC OUTLOOK
  • TABLE 85 NORTH AMERICA: MICROFLUIDICS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 86 NORTH AMERICA: MICROFLUIDICS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 87 NORTH AMERICA: MICROFLUIDIC COMPONENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 88 NORTH AMERICA: MICROFLUIDICS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 89 NORTH AMERICA: MICROFLUIDICS MARKET FOR IVD APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 90 NORTH AMERICA: MICROFLUIDICS MARKET FOR PHARMACEUTICAL & LIFE SCIENCE RESEARCH, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 91 NORTH AMERICA: MICROFLUIDICS MARKET FOR LAB ANALYTICS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 92 NORTH AMERICA: MICROFLUIDICS MARKET FOR THERAPEUTICS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 93 NORTH AMERICA: MICROFLUIDICS COMPONENTS MARKET, BY MATERIAL, 2022-2029 (USD MILLION)
  • TABLE 94 NORTH AMERICA: POLYMER-BASED MICROFLUIDIC COMPONENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 95 NORTH AMERICA: MICROFLUIDICS MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 96 US: KEY MACROINDICATORS
  • TABLE 97 US: MICROFLUIDICS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 98 US: MICROFLUIDIC COMPONENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 99 US: MICROFLUIDIC COMPONENTS MARKET, BY MATERIAL, 2022-2029 (USD MILLION)
  • TABLE 100 US: POLYMER-BASED MICROFLUIDIC COMPONENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 101 CANADA: KEY MACROINDICATORS
  • TABLE 102 CANADA: MICROFLUIDICS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 103 CANADA: MICROFLUIDIC COMPONENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 104 CANADA: MICROFLUIDIC COMPONENTS MARKET, BY MATERIAL, 2022-2029 (USD MILLION)
  • TABLE 105 CANADA: POLYMER-BASED MICROFLUIDIC COMPONENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 106 EUROPE: MACROECONOMIC OUTLOOK
  • TABLE 107 EUROPE: MICROFLUIDICS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 108 EUROPE: MICROFLUIDICS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 109 EUROPE: MICROFLUIDIC COMPONENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 110 EUROPE: MICROFLUIDICS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 111 EUROPE: MICROFLUIDICS MARKET FOR IVD APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 112 EUROPE: MICROFLUIDICS MARKET FOR PHARMACEUTICAL & LIFE SCIENCE RESEARCH APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 113 EUROPE: MICROFLUIDICS MARKET FOR LAB ANALYTICS APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 114 EUROPE: MICROFLUIDICS MARKET FOR THERAPEUTIC APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 115 EUROPE: MICROFLUIDIC COMPONENTS MARKET, BY MATERIAL, 2022-2029 (USD MILLION)
  • TABLE 116 POLYMER-BASED MICROFLUIDIC COMPONENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 117 EUROPE: MICROFLUIDICS MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 118 GERMANY: KEY MACROINDICATORS
  • TABLE 119 GERMANY: MICROFLUIDICS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 120 GERMANY: MICROFLUIDIC COMPONENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 121 GERMANY: MICROFLUIDIC COMPONENTS MARKET, BY MATERIAL, 2022-2029 (USD MILLION)
  • TABLE 122 GERMANY: POLYMER-BASED MICROFLUIDIC COMPONENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 123 FRANCE: KEY MACROINDICATORS
  • TABLE 124 FRANCE: MICROFLUIDICS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 125 FRANCE: MICROFLUIDIC COMPONENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 126 FRANCE: MICROFLUIDIC COMPONENTS MARKET, BY MATERIAL, 2022-2029 (USD MILLION)
  • TABLE 127 FRANCE: POLYMER-BASED MICROFLUIDIC COMPONENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 128 UK: KEY MACROINDICATORS
  • TABLE 129 UK: MICROFLUIDICS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 130 UK: MICROFLUIDIC COMPONENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 131 UK: MICROFLUIDIC COMPONENTS MARKET, BY MATERIAL, 2022-2029 (USD MILLION)
  • TABLE 132 UK: POLYMER-BASED MICROFLUIDIC COMPONENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 133 ITALY: KEY MACROINDICATORS
  • TABLE 134 ITALY: MICROFLUIDICS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 135 ITALY: MICROFLUIDIC COMPONENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 136 ITALY: MICROFLUIDIC COMPONENTS MARKET, BY MATERIAL, 2022-2029 (USD MILLION)
  • TABLE 137 ITALY: POLYMER-BASED MICROFLUIDIC COMPONENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 138 SPAIN: KEY MACROINDICATORS
  • TABLE 139 SPAIN: MICROFLUIDICS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 140 SPAIN: MICROFLUIDIC COMPONENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 141 SPAIN: MICROFLUIDIC COMPONENTS MARKET, BY MATERIAL, 2022-2029 (USD MILLION)
  • TABLE 142 SPAIN: POLYMER-BASED MICROFLUIDIC COMPONENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 143 REST OF EUROPE: MICROFLUIDICS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 144 REST OF EUROPE: MICROFLUIDIC COMPONENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 145 REST OF EUROPE: MICROFLUIDIC COMPONENTS MARKET, BY MATERIAL, 2022-2029 (USD MILLION)
  • TABLE 146 REST OF EUROPE: POLYMER-BASED MICROFLUIDIC COMPONENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 147 ASIA PACIFIC: MACROECONOMIC INDICATORS
  • TABLE 148 ASIA PACIFIC: MICROFLUIDICS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 149 ASIA PACIFIC: MICROFLUIDICS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 150 ASIA PACIFIC: MICROFLUIDIC COMPONENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 151 ASIA PACIFIC: MICROFLUIDICS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 152 ASIA PACIFIC: MICROFLUIDICS MARKET FOR IVD APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 153 ASIA PACIFIC: MICROFLUIDICS MARKET FOR PHARMACEUTICAL & LIFE SCIENCE RESEARCH APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 154 ASIA PACIFIC: MICROFLUIDICS MARKET FOR LAB ANALYTICS APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 155 ASIA PACIFIC: MICROFLUIDICS MARKET FOR THERAPEUTIC APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 156 ASIA PACIFIC: MICROFLUIDIC COMPONENTS MARKET, BY MATERIAL, 2022-2029 (USD MILLION)
  • TABLE 157 ASIA PACIFIC: POLYMER-BASED MICROFLUIDIC COMPONENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 158 ASIA PACIFIC: MICROFLUIDICS MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 159 CHINA: KEY MACROINDICATORS
  • TABLE 160 CHINA: MICROFLUIDICS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 161 CHINA: MICROFLUIDIC COMPONENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 162 CHINA: MICROFLUIDIC COMPONENTS MARKET, BY MATERIAL, 2022-2029 (USD MILLION)
  • TABLE 163 CHINA: POLYMER-BASED MICROFLUIDIC COMPONENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 164 JAPAN: KEY MACROINDICATORS
  • TABLE 165 JAPAN: MICROFLUIDICS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 166 JAPAN: MICROFLUIDIC COMPONENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 167 JAPAN: MICROFLUIDIC COMPONENTS MARKET, BY MATERIAL, 2022-2029 (USD MILLION)
  • TABLE 168 JAPAN: POLYMER-BASED MICROFLUIDIC COMPONENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 169 INDIA: KEY MACROINDICATORS
  • TABLE 170 INDIA: MICROFLUIDICS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 171 INDIA: MICROFLUIDIC COMPONENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 172 INDIA: MICROFLUIDIC COMPONENTS MARKET, BY MATERIAL, 2022-2029 (USD MILLION)
  • TABLE 173 INDIA: POLYMER-BASED MICROFLUIDIC COMPONENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 174 AUSTRALIA: KEY MACROINDICATORS
  • TABLE 175 AUSTRALIA: MICROFLUIDICS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 176 AUSTRALIA: MICROFLUIDIC COMPONENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 177 AUSTRALIA: MICROFLUIDIC COMPONENTS MARKET, BY MATERIAL, 2022-2029 (USD MILLION)
  • TABLE 178 AUSTRALIA: POLYMER-BASED MICROFLUIDIC COMPONENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 179 SOUTH KOREA: KEY MACROINDICATORS
  • TABLE 180 SOUTH KOREA: MICROFLUIDICS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 181 SOUTH KOREA: MICROFLUIDIC COMPONENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 182 SOUTH KOREA: MICROFLUIDIC COMPONENTS MARKET, BY MATERIAL, 2022-2029 (USD MILLION)
  • TABLE 183 SOUTH KOREA: POLYMER-BASED MICROFLUIDIC COMPONENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 184 REST OF ASIA PACIFIC: MICROFLUIDICS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 185 REST OF ASIA PACIFIC: MICROFLUIDIC COMPONENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 186 REST OF ASIA PACIFIC: MICROFLUIDIC COMPONENTS MARKET, BY MATERIAL, 2022-2029 (USD MILLION)
  • TABLE 187 REST OF ASIA PACIFIC: POLYMER-BASED MICROFLUIDIC COMPONENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 188 LATIN AMERICA: MACROECONOMIC OUTLOOK
  • TABLE 189 LATIN AMERICA: MICROFLUIDICS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 190 LATIN AMERICA: MICROFLUIDICS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 191 LATIN AMERICA: MICROFLUIDIC COMPONENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 192 LATIN AMERICA: MICROFLUIDICS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 193 LATIN AMERICA: MICROFLUIDICS MARKET FOR IVD APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 194 LATIN AMERICA: MICROFLUIDICS MARKET FOR PHARMACEUTICAL & LIFE SCIENCE RESEARCH APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 195 LATIN AMERICA: MICROFLUIDICS MARKET FOR LAB ANALYTICS APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 196 LATIN AMERICA: MICROFLUIDICS MARKET FOR THERAPEUTIC APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 197 LATIN AMERICA: POLYMER-BASED MICROFLUIDIC COMPONENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 198 LATIN AMERICA: MICROFLUIDIC COMPONENTS MARKET, BY MATERIAL, 2022-2029 (USD MILLION)
  • TABLE 199 LATIN AMERICA: MICROFLUIDICS MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 200 BRAZIL: KEY MACROINDICATORS
  • TABLE 201 BRAZIL: MICROFLUIDICS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 202 BRAZIL: MICROFLUIDIC COMPONENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 203 BRAZIL: MICROFLUIDICS COMPONENT MARKET, BY MATERIAL, 2022-2029 (USD MILLION)
  • TABLE 204 BRAZIL: POLYMER-BASED MICROFLUIDIC COMPONENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 205 MEXICO: KEY MACROINDICATORS
  • TABLE 206 MEXICO: MICROFLUIDICS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 207 MEXICO: MICROFLUIDIC COMPONENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 208 MEXICO: MICROFLUIDICS MARKET, MICROFLUIDIC COMPONENTS MARKET, BY MATERIAL, 2022-2029 (USD MILLION)
  • TABLE 209 MEXICO: POLYMER-BASED MICROFLUIDIC COMPONENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 210 REST OF LATIN AMERICA: MICROFLUIDICS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 211 REST OF LATIN AMERICA: MICROFLUIDIC COMPONENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 212 REST OF LATIN AMERICA: MICROFLUIDIC COMPONENTS MARKET, BY MATERIAL, 2022-2029 (USD MILLION)
  • TABLE 213 REST OF LATIN AMERICA: POLYMER-BASED MICROFLUIDIC COMPONENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 214 MIDDLE EAST & AFRICA: MICROFLUIDICS MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 215 MIDDLE EAST & AFRICA: MACROECONOMIC OUTLOOK
  • TABLE 216 MIDDLE EAST & AFRICA: MICROFLUIDICS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 217 MIDDLE EAST & AFRICA: MICROFLUIDIC COMPONENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 218 MIDDLE EAST & AFRICA: MICROFLUIDICS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 219 MIDDLE EAST & AFRICA: MICROFLUIDICS MARKET FOR IVD APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 220 MIDDLE EAST & AFRICA: MICROFLUIDICS MARKET FOR PHARMACEUTICAL & LIFE SCIENCE RESEARCH APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 221 MIDDLE EAST & AFRICA: MICROFLUIDICS MARKET FOR LAB ANALYTICS APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 222 MIDDLE EAST & AFRICA: MICROFLUIDICS MARKET FOR THERAPEUTIC APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 223 MIDDLE EAST & AFRICA: MICROFLUIDIC COMPONENTS MARKET, BY MATERIAL, 2022-2029 (USD MILLION)
  • TABLE 224 MIDDLE EAST & AFRICA: POLYMER-BASED MICROFLUIDIC COMPONENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 225 MIDDLE EAST & AFRICA: MICROFLUIDICS MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 226 GCC COUNTRIES: MICROFLUIDICS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 227 GCC COUNTRIES: MICROFLUIDIC COMPONENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 228 GCC COUNTRIES: MICROFLUIDIC COMPONENTS MARKET, BY MATERIAL, 2022-2029 (USD MILLION)
  • TABLE 229 GCC COUNTRIES: POLYMER-BASED MICROFLUIDIC COMPONENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 230 REST OF MIDDLE EAST & AFRICA: MICROFLUIDICS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 231 REST OF MIDDLE EAST & AFRICA: MICROFLUIDIC COMPONENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 232 REST OF MIDDLE EAST & AFRICA: MICROFLUIDIC COMPONENTS MARKET, BY MATERIAL, 2022-2029 (USD MILLION)
  • TABLE 233 REST OF MIDDLE EAST & AFRICA: POLYMER-BASED MICROFLUIDIC COMPONENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 234 OVERVIEW OF STRATEGIES DEPLOYED BY KEY MANUFACTURING COMPANIES
  • TABLE 235 MICROFLUIDICS MARKET: DEGREE OF COMPETITION
  • TABLE 236 MICROFLUIDICS MARKET: PRODUCT FOOTPRINT
  • TABLE 237 MICROFLUIDICS MARKET: APPLICATION FOOTPRINT
  • TABLE 238 MICROFLUIDICS MARKET: END-USER FOOTPRINT
  • TABLE 239 MICROFLUIDICS MARKET: REGION FOOTPRINT
  • TABLE 240 MICROFLUIDICS MARKET: DETAILED LIST OF KEY STARTUP/SME PLAYERS
  • TABLE 241 MICROFLUIDICS MARKET: COMPETITIVE BENCHMARKING OF KEY EMERGING PLAYERS/STARTUPS
  • TABLE 242 MICROFLUIDICS MARKET: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021-AUGUST 2024
  • TABLE 243 MICROFLUIDICS MARKET: DEALS, JANUARY 2021-AUGUST 2024
  • TABLE 244 MICROFLUIDICS MARKET: EXPANSIONS, JANUARY 2021-AUGUST 2024
  • TABLE 245 MICROFLUIDICS MARKET: OTHER DEVELOPMENTS, JANUARY 2021-AUGUST 2024
  • TABLE 246 DANAHER CORPORATION: COMPANY OVERVIEW
  • TABLE 247 DANAHER CORPORATION: PRODUCTS OFFERED
  • TABLE 248 DANAHER CORPORATION: DEALS, JANUARY 2021-AUGUST 2024
  • TABLE 249 DANAHER CORPORATION: EXPANSIONS, JANUARY 2021-AUGUST 2024
  • TABLE 250 ILLUMINA, INC.: COMPANY OVERVIEW
  • TABLE 251 ILLUMINA INC.: PRODUCTS OFFERED
  • TABLE 252 ILLUMINA, INC.: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021-AUGUST 2024
  • TABLE 253 ILLUMINA, INC.: DEALS, JANUARY 2021-AUGUST 2024
  • TABLE 254 BIOMERIEUX: COMPANY OVERVIEW
  • TABLE 255 BIOMERIEUX: PRODUCTS OFFERED
  • TABLE 256 BIOMERIEUX: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021-AUGUST 2024
  • TABLE 257 THERMO FISHER SCIENTIFIC INC.: COMPANY OVERVIEW
  • TABLE 258 THERMO FISHER SCIENTIFIC INC.: PRODUCTS OFFERED
  • TABLE 259 THERMO FISHER SCIENTIFIC INC.: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021-AUGUST 2024
  • TABLE 260 THERMO FISHER SCIENTIFIC INC.: DEALS, JANUARY 2021-AUGUST 2024
  • TABLE 261 THERMO FISHER SCIENTIFIC INC.: EXPANSIONS, JANUARY 2021-AUGUST 2024
  • TABLE 262 ABBOTT LABORATORIES: COMPANY OVERVIEW
  • TABLE 263 ABBOTT LABORATORIES: PRODUCTS OFFERED
  • TABLE 264 PARKER HANNIFIN CORP: COMPANY OVERVIEW
  • TABLE 265 PARK HANNIFIN CORP: PRODUCTS OFFERED
  • TABLE 266 SMC CORPORATION: COMPANY OVERVIEW
  • TABLE 267 SMC CORPORATION: PRODUCTS OFFERED
  • TABLE 268 SMC CORPORATION: PRODUCT LAUNCHES, JANUARY 2021-AUGUST 2024
  • TABLE 269 IDEX CORPORATION: COMPANY OVERVIEW
  • TABLE 270 IDEX CORPORATION: PRODUCTS OFFERED
  • TABLE 271 IDEX CORPORATION: DEALS, JANUARY 2021-AUGUST 2024
  • TABLE 272 FORTIVE: COMPANY OVERVIEW
  • TABLE 273 FORTIVE: PRODUCTS OFFERED
  • TABLE 274 PERKINELMER INC.: COMPANY OVERVIEW
  • TABLE 275 PERKINELMER INC.: PRODUCTS OFFERED
  • TABLE 276 PERKINELMER INC.: PRODUCT LAUNCHES, JANUARY 2021-AUGUST 2024
  • TABLE 277 PERKINELMER INC.: DEALS, JANUARY 2021-AUGUST 2024
  • TABLE 278 AGILENT TECHNOLOGIES, INC.: COMPANY OVERVIEW
  • TABLE 279 AGILENT TECHNOLOGIES, INC.: PRODUCTS OFFERED
  • TABLE 280 AGILENT TECHNOLOGIES, INC.: PRODUCT LAUNCHES, JANUARY 2021-AUGUST 2024
  • TABLE 281 AGILENT TECHNOLOGIES, INC.: DEALS, JANUARY 2021-AUGUST 2024
  • TABLE 282 AGILENT TECHNOLOGIES, INC.: EXPANSIONS, JANUARY 2021-AUGUST 2024
  • TABLE 283 BIO-RAD LABORATORIES, INC.: COMPANY OVERVIEW
  • TABLE 284 BIO-RAD LABORATORIES, INC.: PRODUCTS OFFERED
  • TABLE 285 BIO-RAD LABORATORIES, INC.: PRODUCT LAUNCHES, JANUARY 2021-AUGUST 2024
  • TABLE 286 BIO-RAD LABORATORIES, INC.: DEALS, JANUARY 2021-AUGUST 2024
  • TABLE 287 BECTON, DICKINSON AND COMPANY: COMPANY OVERVIEW
  • TABLE 288 BECTON, DICKINSON AND COMPANY: PRODUCTS OFFERED
  • TABLE 289 BECTON, DICKINSON AND COMPANY: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021-AUGUST 2024
  • TABLE 290 BECTON, DICKINSON AND COMPANY: DEALS, JANUARY 2021-AUGUST 2024
  • TABLE 291 BECTON, DICKINSON AND COMPANY: EXPANSIONS, JANUARY 2021-AUGUST 2024
  • TABLE 292 F. HOFFMANN-LA ROCHE LTD.: COMPANY OVERVIEW
  • TABLE 293 F. HOFFMANN-LA ROCHE LTD.: PRODUCTS OFFERED
  • TABLE 294 F. HOFFMANN-LA ROCHE LTD: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021-AUGUST 2024
  • TABLE 295 F. HOFFMANN-LA ROCHE LTD: DEALS, JANUARY 2021-AUGUST 2024
  • TABLE 296 STANDARD BIOTOOLS: COMPANY OVERVIEW
  • TABLE 297 STANDARD BIOTOOLS: PRODUCTS OFFERED
  • TABLE 298 STANDARD BIOTOOLS: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021-AUGUST 2024
  • TABLE 299 STANDARD BIOTOOLS: DEALS, JANUARY 2021-AUGUST 2024
  • TABLE 300 QUIDELORTHO CORPORATION: COMPANY OVERVIEW
  • TABLE 301 QUIDELORTHO CORPORATION: PRODUCTS OFFERED
  • TABLE 302 QUIDELORTHO CORPORATION: PRODUCT APPROVALS, JANUARY 2021-AUGUST 2024
  • TABLE 303 QUIDELORTHO CORPORATION: DEALS, JANUARY 2021-AUGUST 2024
  • TABLE 304 QUIDELORTHO CORPORATION: EXPANSIONS, JANUARY 2021-AUGUST 2024
  • TABLE 305 HOLOGIC, INC.: COMPANY OVERVIEW
  • TABLE 306 HOLOGIC, INC.: PRODUCTS OFFERED
  • TABLE 307 HOLOGIC, INC: PRODUCT APPROVALS, JANUARY 2021-AUGUST 2024
  • TABLE 308 HOLOGIC, INC: DEALS, JANUARY 2021-AUGUST 2024
  • TABLE 309 AIGNEP S.P.A.: COMPANY OVERVIEW
  • TABLE 310 AIGNEP S.P.A.: PRODUCTS OFFERED
  • TABLE 311 AIGNEP S.P.A.: DEALS, JANUARY 2021-AUGUST 2024
  • TABLE 312 DOLOMITE MICROFLUIDICS: COMPANY OVERVIEW
  • TABLE 313 DOLOMITE MICROFLUIDICS: PRODUCTS OFFERED
  • TABLE 314 DOLOMITE MICROFLUIDICS: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021-AUGUST 2024
  • TABLE 315 DOLOMITE MICROFLUIDICS: DEALS, JANUARY 2021-AUGUST 2024
  • TABLE 316 DOLOMITE MICROFLUIDICS: OTHER DEVELOPMENTS, JANUARY 2021-AUGUST 2024
  • TABLE 317 ELVEFLOW: COMPANY OVERVIEW
  • TABLE 318 ELVEFLOW: PRODUCTS OFFERED
  • TABLE 319 NANOSTRING TECHNOLOGIES: COMPANY OVERVIEW
  • TABLE 320 NORTIS INC.: COMPANY OVERVIEW
  • TABLE 321 INNOVATIVE BIOCHIPS, LLC: COMPANY OVERVIEW
  • TABLE 322 FLUIDIC ANALYTICS: COMPANY OVERVIEW
  • TABLE 323 UFLUIDIX: COMPANY OVERVIEW
  • TABLE 324 HORIBA: COMPANY OVERVIEW
  • TABLE 325 MICRONIT B.V.: COMPANY OVERVIEW

List of Figures

  • FIGURE 1 MICROFLUIDICS MARKET SEGMENTATION
  • FIGURE 2 MICROFLUIDICS MARKET: RESEARCH DESIGN
  • FIGURE 3 PRIMARY SOURCES
  • FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
  • FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS
  • FIGURE 6 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING
  • FIGURE 7 MICROFLUIDICS MARKET SIZE ESTIMATION: APPROACH 1 (COMPANY REVENUE ESTIMATION)
  • FIGURE 8 MICROFLUIDICS MARKET SIZE ESTIMATION: BOTTOM-UP APPROACH
  • FIGURE 9 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
  • FIGURE 10 TOP-DOWN APPROACH
  • FIGURE 11 DATA TRIANGULATION
  • FIGURE 12 MICROFLUIDICS MARKET, BY PRODUCT, 2024 VS. 2029 (USD MILLION)
  • FIGURE 13 MICROFLUIDIC COMPONENTS MARKET, BY TYPE, 2024 VS. 2029 (USD MILLION)
  • FIGURE 14 MICROFLUIDICS MARKET, BY APPLICATION, 2024 VS. 2029 (USD MILLION)
  • FIGURE 15 MICROFLUIDICS MARKET, BY END USER, 2024 VS. 2029 (USD MILLION)
  • FIGURE 16 GEOGRAPHICAL SNAPSHOT OF MICROFLUIDICS MARKET, 2024-2029
  • FIGURE 17 GROWING DEMAND FOR POINT-OF-CARE TESTING TO DRIVE MARKET
  • FIGURE 18 HOSPITALS AND DIAGNOSTIC CENTERS SEGMENT ACCOUNTED FOR LARGEST MARKET SHARE FOR JAPAN IN 2023
  • FIGURE 19 NORTH AMERICA TO DOMINATE MICROFLUIDICS MARKET IN 2024
  • FIGURE 20 CHINA TO ACCOUNT FOR HIGHEST GROWTH RATE DURING FORECAST PERIOD
  • FIGURE 21 MICROFLUIDICS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • FIGURE 22 GLOBAL CANCER INCIDENCE, 2020-2040
  • FIGURE 23 MICROFLUIDICS MARKET: PORTER'S FIVE FORCES ANALYSIS
  • FIGURE 24 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR MICROFLUIDICS MARKET, BY MATERIAL
  • FIGURE 25 KEY BUYING CRITERIA, BY MATERIAL
  • FIGURE 26 US: REGULATORY PROCESS FOR TESTING DEVICES ASSOCIATED WITH MICROFLUIDICS TECHNOLOGY
  • FIGURE 27 CANADA: REGULATORY PROCESS FOR MICROFLUIDICS-ASSOCIATED IVD DEVICES IN CANADA
  • FIGURE 28 EUROPE: REGULATORY PROCESS FOR IVD DEVICES
  • FIGURE 29 INDIA: REGULATORY PROCESS FOR IVD DEVICES
  • FIGURE 30 MICROFLUIDICS MARKET: ECOSYSTEM ANALYSIS
  • FIGURE 31 MICROFLUIDICS MARKET: VALUE CHAIN ANALYSIS
  • FIGURE 32 MICROFLUIDICS MARKET: SUPPLY CHAIN ANALYSIS
  • FIGURE 33 REVENUE SHIFT AND NEW REVENUE POCKETS
  • FIGURE 34 TOP APPLICANTS AND OWNERS (COMPANIES/INSTITUTIONS) FOR MICROFLUIDICS PATENTS (JANUARY 2014-AUGUST 2024)
  • FIGURE 35 AVERAGE SELLING PRICE TREND OF PRODUCTS, BY REGION, 2021- 2023 (USD)
  • FIGURE 36 AVERAGE SELLING PRICE OF TOP 3 APPLICATIONS, BY KEY PLAYER
  • FIGURE 37 INVESTMENT & FUNDING SCENARIO, 2019-2023
  • FIGURE 38 NUMBER OF INVESTOR DEALS, BY KEY PLAYERS, 2019-2023
  • FIGURE 39 VALUE OF INVESTOR DEALS BY KEY PLAYERS, 2019-2023 (USD MILLION)
  • FIGURE 40 NORTH AMERICA: MICROFLUIDICS MARKET SNAPSHOT
  • FIGURE 41 ASIA PACIFIC: MICROFLUIDICS MARKET SNAPSHOT
  • FIGURE 42 REVENUE ANALYSIS OF KEY PLAYERS IN MICROFLUIDICS MARKET (2019-2023)
  • FIGURE 43 MARKET SHARE ANALYSIS OF KEY PLAYERS IN MICROFLUIDICS MARKET (2023)
  • FIGURE 44 RANKING OF KEY PLAYERS IN MICROFLUIDICS MARKET, 2023
  • FIGURE 45 MICROFLUIDICS MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2023
  • FIGURE 46 MICROFLUIDICS MARKET: COMPANY FOOTPRINT
  • FIGURE 47 MICROFLUIDICS MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2023
  • FIGURE 48 EV/EBITDA OF KEY VENDORS
  • FIGURE 49 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS
  • FIGURE 50 MICROFLUIDICS MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS
  • FIGURE 51 DANAHER CORPORATION: COMPANY SNAPSHOT (2023)
  • FIGURE 52 ILLUMINA, INC.: COMPANY SNAPSHOT (2023)
  • FIGURE 53 BIOMERIEUX: COMPANY SNAPSHOT (2023)
  • FIGURE 54 THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT (2023)
  • FIGURE 55 ABBOTT LABORATORIES: COMPANY SNAPSHOT (2023)
  • FIGURE 56 PARKER HANNIFIN CORP: COMPANY SNAPSHOT (2023)
  • FIGURE 57 SMC CORPORATION: COMPANY SNAPSHOT (2023)
  • FIGURE 58 IDEX CORPORATION: COMPANY SNAPSHOT (2023)
  • FIGURE 59 FORTIVE: COMPANY SNAPSHOT (2023)
  • FIGURE 60 PERKINELMER INC.: COMPANY SNAPSHOT (2023)
  • FIGURE 61 AGILENT TECHNOLOGIES, INC.: COMPANY SNAPSHOT (2023)
  • FIGURE 62 BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT (2023)
  • FIGURE 63 BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT (2023)
  • FIGURE 64 F. HOFFMANN-LA ROCHE LTD.: COMPANY SNAPSHOT (2023)
  • FIGURE 65 STANDARD BIOTOOLS: COMPANY SNAPSHOT (2023)
  • FIGURE 66 QUIDELORTHO CORPORATION: COMPANY SNAPSHOT (2023)
  • FIGURE 67 HOLOGIC, INC.: COMPANY SNAPSHOT (2023)